Article Information
- Received September 2, 1998
- Revision received November 2, 1998
- Accepted November 4, 1998
- First published January 15, 1999.
- Version of record published January 15, 1999.
Author Information
Author contributions
Disclosures
- Received September 2, 1998.
- Revision received November 2, 1998.
- Accepted November 4, 1998.
↵3 R.L.M. and M.S. contributed equally to this work.
Correspondence should be addressed to Dr. Catherina G. Becker, Zentrum für Molekulare Neurobiologie Hamburg, Universität Hamburg, D-20246 Hamburg, Germany.
This work was supported by postdoctoral fellowships from the Europen Molecular Biology Organization to C.G.B., the European Union to T.B., and the Deutsche Forschungsgemeinschaft to C.G.B. (Be 1654/2-1) and T.B. (Be 1650/1-1), National Institutes of Health Grant NS26750 to R.L.M., and the Sir Jules Thorn Trust. We thank Drs. Zhi-cheng Xiao and Birgit Hertlein for tenascin-R fragments, Dr. Joanne Taylor for purified tenascin-R, Jill Miotke for introduction to retinal explant culture, Dr. Rita Gerardy-Schahn for the MG5 antibody, and Dr. Udo Bartsch for helpful discussions and critically reading this manuscript.
Online Impact